Drugmaker Eli Lilly & Co. said Monday that a second drug that modestly slows the progression of Alzheimer’s disease could be approved by the end of this year. The manufacturer said donanemab sig… [+2875 chars]Read More
Eli Lilly says FDA approval of Alzheimers drug donanemab could come later this year Fox Business
